Zymeworks (ZYME) Non Operating Income (2021 - 2026)
Zymeworks' (ZYME) quarterly Non Operating Income came in at $120000.0 in Q1 2026, up 144.9% year-on-year from $49000.0 in Q1 2025, and up 139.74% quarter-over-quarter from -$302000.0 in Q4 2025.
Zymeworks (ZYME) Non Operating Income (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Non Operating Income across 6 years of filings, most recently posting $120000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $120000.0, up 144.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$488000.0 (down 261.06% YoY), and the FY2025 annual result was -$559000.0, down 200.18% from the prior year.
- Non Operating Income came in at $120000.0 for Q1 2026 at Zymeworks, up from -$302000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.4 million in Q3 2022 to a low of -$832000.0 in Q4 2023.
- The 5-year median for Non Operating Income is $49000.0 (2025), against an average of $19705.9.
- Across the five-year window, Non Operating Income slumped 2406.67% in 2022 and jumped 254.41% in 2025, its largest moves.
- Zymeworks' Non Operating Income stood at -$692000.0 in 2022, then dropped by 20.23% to -$832000.0 in 2023, then surged by 141.35% to $344000.0 in 2024, then slumped by 187.79% to -$302000.0 in 2025, then soared by 139.74% to $120000.0 in 2026.
- The last three Non Operating Income figures came in at $120000.0 (Q1 2026), -$302000.0 (Q4 2025), and $315000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | -302,000.00 |
| Sep 30, 2025 | 315,000.00 |
| Jun 30, 2025 | -621,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 344,000.00 |
| Sep 30, 2024 | -204,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | -832,000.00 |
| Sep 30, 2023 | 634,000.00 |
| Jun 30, 2023 | -209,000.00 |
| Mar 31, 2023 | -487,000.00 |
| Dec 31, 2022 | -692,000.00 |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 759,000.00 |
| Mar 31, 2022 | -315,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 1.15 Mn |